FIGURE 5.

Probability of first fistula relapse over time for patients who were in remission 52 weeks after treatment with darvadstrocel vs control. CI, confidence interval; HR, hazard ratio. ^aBaseline characteristics accounted in the adjusted HR include age, sex, perianal fistulizing disease duration, and baseline Crohn\'s Disease Activity Index score. Censoring rules are that patients are counted as an event at first documentation of the outcome or as a right-censored value at the end of follow-up (i.e. earliest of 104 weeks after ADMIRE-CD, death, or last contact with site). Patient numbers represent the analysis population subject to availability of data.